Trial Profile
A outcome trial of sofosbuvir based antiviral therapy for hepatitis-C after liver transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 20 Dec 2015 New trial record